StockData
Kamada Ltd logo

Kamada Ltd (KMDA) stock

KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026Score 5/30
$8.16+0.05 (+0.62%)

Close on Nov 17, 2026Market cap $470.72MP/E –Yield –

Kamada price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Kamada's price to sales ratio was 2.6× on Apr 30, 2026, against 2.3× a year earlier. Over the last 5 years it ranged from 1.5× to 3.1×, with a median of 2.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 20262.6×+0.3
2025Apr 30, 20252.3×+0.2
2024Apr 30, 20242.1×+0.5
2023Apr 28, 20231.6×−0.7
2022Apr 29, 20222.3×+0.5
2021Jul 30, 20211.8×−0.2
2020Dec 31, 20202.1×−0.3
2019Dec 31, 20192.4×+0.4
2018Dec 31, 20182.0×−0.3
2017Dec 29, 20172.2×−0.6
2016Dec 30, 20162.8×–

More Kamada figures

See a number that looks wrong?